Ischemic stroke patients not receiving life-saving treatment, study finds

Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers.
Source: Feed4

Leave a Reply

Your email address will not be published. Required fields are marked *